Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for ...

Longboard Pharmaceuticals Inc.的股价已达到令人印象深刻的里程碑，创下58.92美元的历史新高。这一峰值反映了投资者信心的显著增强，从公司673.36%的一年涨幅可见一斑。制药行业一直密切关注Longboard ...

The companies said Lundbeck will acquire all of Longboard's shares for $60 per share, which represents a premium of 54.2% to ...

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...

Rachael Tilly and Taylor Jensen won the Surf City El Salvador Longboard Championships to claim 2024 World Longboard Titles.

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...

，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals (LBPH.US)。在这一重磅消息刺激之下，截至发稿，Longboard股价在美股盘前交易中的涨幅超过50%。截至上周美股收盘，Longboard总市值约15亿美元，股价则收于38.90美元，均远低于 Lundbeck发起的收购规模 。

Longboard Pharmaceuticals shares surged by more than 50%, and hit an all-time high Monday, after the clinical-stage biopharmaceutical company agreed to be acquired by Danish drugmaker H. Lundbeck for ...

Shares of Longboard Pharmaceuticals Inc. were soaring more than 51% on Monday after the announcement of H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical ...

Danish pharmaceutical giant H. Lundbeck A/S has struck a $2.6 billion deal to acquire Longboard Pharmaceuticals, a U.S.-based ...